P1444: IMPACT OF CO-MORBIDITIES ON NON-RELAPSE MORTALITY AND CYTOKINE-RELEASE SYNDROME AFTER CD19 CAR-T CELL THERAPY - A RETROSPECTIVE STUDY FROM THE TCWP OF THE EBMT AND GOCART COALITION

• G. Basak,
• C. Peczynski,
• C. Koenecke,
• S. Terwel,
• Y. Cabrerizo,
• O. Penack,
• I. Moiseev,
• H. Schoemans,
• N. Fegueux,
• V. Potter,
• S. Zeerleder,
• I. Yakoub-Agha,
• M. Collin,
• U. Schanz,
• P. Dreger,
• D. Blaise,
• C. Besley,
• B. Glass,
• M. Mohty,
• C. Chabannon,
• J. Kuball,
• J. Snowden,
• A. Sureda,
• N. Kröger,
• Z. Peric

Affiliations

G. Basak

1 Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland

C. Peczynski

2 EBMT Transplant Complications Working Party, EBMT, Paris, France

C. Koenecke

3 Clinic for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

S. Terwel

4 The GoCART Coalition, EBMT Executive Office, EBMT, Leiden

Y. Cabrerizo

5 Tthe GoCART Coalition, EHA Executive Office, EHA, Hague, Netherlands

O. Penack

6 Medical Clinic, Department of Haematology, Oncology and Tumor Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany

I. Moiseev

7 RM Gorbacheva Research Institute, Pavlov University, St Petersburg, Russia

H. Schoemans

8 Department of Hematology, Department of Public Health and Primary Care, University Hospitals Leuven, University of Leuven, Leuven, Belgium

N. Fegueux

9 Département d`Hématologie Clinique, CHU Lapeyronie, Montpellier, France

V. Potter

10 Dept. of Haematological Medicine, Kings College Hospital, London, United Kingdom

S. Zeerleder

11 Paediatric Hematology/Oncology, University Hospital Bern, Bern, Switzerland

I. Yakoub-Agha

12 CHU de Lille, LIRIC, INSERM U995, Université de Lille, Lille, France

M. Collin

13 Adult HSCT unit, Northern Centre for Bone Marrow Transplantation, Freeman Hospital, Newcastle Tyne, United Kingdom

U. Schanz

14 Clinic of Medical Oncology and Hematology, University Hospital and University of Zurich, Zurich, Switzerland

P. Dreger

15 Medizinische Klinik u. Poliklinik V, University of Heidelberg, Heidelberg, Germany

D. Blaise

16 Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France

C. Besley

17 Dept. of Paediatric Oncology/BMT, Bristol Royal Hospital for Children, Bristol, United Kingdom

B. Glass

18 AbteilungHämatologie und Stammzelltransplantation, AsklepiosKlinik St Georg, Hamburg, Germany

M. Mohty

19 Service d’hématologie clinique et thérapie cellulaire, Hôpital Saint-Antoine, INSERM UMRs 938 and Université Sorbonne, Paris

C. Chabannon

20 Centre d’Investigations Cliniques en Biothérapies, Institut Paoli-Calmettes Comprehensive Cancer Center, Aix-Marseille Université School of Medicine & Inserm CBT1409, Marseille, France

J. Kuball

21 Department of Haematology, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands

J. Snowden

22 Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

A. Sureda

23 Institut Català d’Oncologia-Hospitalet, Institut d’Investigació Biomedica de Bellvitge, Universitat de Barcelona, Barcelona, Spain

N. Kröger

24 Bone Marrow Transplantation Centre, University Hospital Eppendorf, Hamburg, Germany

Z. Peric

25 Department of Hematology, University Hospital Centre Zagreb, Zagreb, Croatia